Verve Therapeutics (VERV)
(Delayed Data from NSDQ)
$5.61 USD
-0.01 (-0.18%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $5.62 +0.01 (0.18%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Brokerage Reports
0 items in cart
Verve Therapeutics, Inc. [VERV]
Reports for Purchase
Showing records 1 - 4 ( 4 total )
Company: Verve Therapeutics, Inc.
Industry: Medical - Drugs
VERVE-102 Phase 1b Data Slated for 1H25; 2Q24 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Verve Therapeutics, Inc.
Industry: Medical - Drugs
VERVE-102 Phase 1b Trial Underway; 1Q24 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Verve Therapeutics, Inc.
Industry: Medical - Drugs
Don''t Have a Heart Attack; Base Editing Platform; Initiate at Buy and $15 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Verve Therapeutics, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for VERV 112223
Provider: Stock Traders Daily
Analyst: Research Department
|